Acta Scientific Otolaryngology (ASOL) (ISSN: 2582-5550)

Perspective Volume 4 Issue 4

Corona Virus “Delta variant” Effect on Otolaryngology

Ahmet Baki*

Department of Otolaryngology, Başakşehir Çam and Sakura City Hospital/Turkey

*Corresponding Author: Ahmet Baki, Department of Otolaryngology, Başakşehir Çam and Sakura City Hospital/Turkey.

Received: January 15, 2022; Published: March 14, 2022

The clinical findings of COVID-19 developing with the delta variant show a different course from the classical COVID-19 clinical results. Cold symptoms such as sore throat, runny nose, and headache develop more dominantly than classical findings such as fever [1]. The delta coronavirus variant, first discovered in India, may be causing symptoms not typically seen in COVID-19 patients. These symptoms include stomach pain, nausea, vomiting, loss of appetite, hearing loss and joint pain, according to six physicians treating COVID-19 patients across the country [2].


  2. Mackenzie Bean - Tuesday, June 8th, (2021).
  3. Wang D., et al. “Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China”. JAMA11 (2020): 1061-1069.
  4. Lauring AS and Malani PN. “Variants of SARS-CoV-2”. JAMA (2021).
  5. Walensky RP., et al. “SARS-CoV-2 variants of concern in the United States”. JAMA 11 (2021): 1037-1038.
  6. World Health Organization. COVID-19 weekly epidemiological update: edition 45, 22 June 2021. Geneva: World Health Organization (2021).
  7. Twohig KA., et al. “Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study”. Lancet Infectious Disease1 (2021): 35-42.
  8. Navaratnam AV., et al. “Patient factors and temporal trends associated with COVID-19 in-hospital mortality in England: an observational study using administrative data”. Lancet Respiratory Medicine 9 (2021): 397-406.
  9. Salleh MZ., et al. “Structural evaluation of the spike glycoprotein variants on SARS-CoV-2 transmission and immune evasion”. International Journal of Molecular Sciences 22 (2021): 7425.
  10. COVID-19 and hearing loss: What we know Contributed by Joy Victory, managing editor, Healthy Hearing Last updated August 30 (2021).
  11. Mary Kate Brogan University Public Affairs Phone (804) 828-7701.
  12. Blog, Covid-related, Dr. AARON ROGERS, UNIQUE CONTENT Post COVID Sinus Infections.
  13. My MedlinePlus Weekly Newsletter: Delta Variant: What We Know About the Science MedlinePlus sent this bulletin at 08/18/2021.


Citation: Ahmet Baki. “Corona Virus “Delta variant” Effect on Otolaryngology".Acta Scientific Otolaryngology 4.4 (2022): 21-22.


Copyright: © 2022 Ahmet Baki. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate34%
Acceptance to publication20-30 days
Impact Factor0.871

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US